Salt Lake City, October 21, 2019— Leavitt Partners and the Duke-Margolis Center for Health Policy released “Spread of ACOs And Value-Based Payment Models In 2019: Gauging the Impact of Pathways to Success,” which leveraged data from Torch Insight, a robust, market-centric data integration and analytics platform developed by Leavitt Partners Insight. This annual paper summarizes the … Read more
Salt Lake City, June 22, 2018 — Leavitt Partners is pleased to announce that the firm will present 12 research posters at the AcademyHealth Annual Research Meeting in Seattle, WA June 24-26, 2018. The Annual Research Meeting (ARM) is the premier forum for health services research, with a program designed specifically for health services researchers, … Read more
Salt Lake City, June 23, 2017 — Leavitt Partners is pleased to announce that the firm will present 10 research posters and provide three presentations, supported by eleven researchers, at the AcademyHealth Annual Research Meeting (ARM) in New Orleans, LA June 25-27, 2017. The ARM is the premier forum for health services research, with a … Read more
New Report Analyzes the Expanding Landscape of Value-Based Entities Research from HMA and LP VBP experts segments and sizes the growing enabler market, considering benefits and risks, and proposing guiding principles and policy recommendations for the CMS Innovation Center A new in-depth HMA report analyzes the landscape of emerging value-based entities and the implications … Read more
The Save Rare Treatments Task Force, a new multi-sector public policy and advocacy collaboration convened by Leavitt Partners, an HMA Company, publicly launched this week and today released a letter of support for recently introduced, bipartisan, bicameral legislation. The Task Force is comprised of organizations representing persons living with rare diseases, biopharmaceutical innovators, and other … Read more
In “Aggregated Precision Investment: Strengths, Weaknesses, and Potential Paths Forward,” Rebecca Nielsen, Brooke Zollinger, and Sarah Johnson from Leavitt Partners explore the feasibility of operationalizing an aggregated precision investment (API) model for social determinants of health (SDOH) interventions. The authors derive their findings from subject matter expert interviews, conversations with potential aggregators, and relevant secondary research. This article enumerates … Read more
Amy Comstock Rick, former president and chief executive officer (CEO) of the Food and Drug Law Institute (FDLI), joined Leavitt Partners, an HMA Company as a principal on March 20. Rick has over 30 years of experience leading organizations, executing strategy, transforming organizational culture, building consensus, and advocating policies across constituencies. “Amy is widely respected … Read more
Data science and digital health in clinical development and operations: impact, challenges, and calls to action for the drug development ecosystem In this paper, the Medicines Development Modernization Initiative discuss how three medicines development tools (MDTs) – artificial intelligence (AI) and machine learning (ML) algorithms, digital health tools (DHTs), and augmentation of randomized controlled trial … Read more
The Dual Eligible Coalition
How We Help Providers How We Help Providers Leavitt Partners offers a seasoned team of health care leaders and policy experts to support providers during every stage of their transition to value-based payment models, from the time they are considering the transformation – to researching the dynamics of their local market – to developing and … Read more
